The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises (original) (raw)
Related papers
Journal of Medicinal Chemistry, 2015
Molecular Pathways: YAP and TAZ Take Center Stage in Organ Growth and Tumorigenesis
Clinical Cancer Research, 2013
Cancers
YAP/TAZ at the Roots of Cancer
Cancer Cell, 2016
A feed forward loop enforces YAP/TAZ signaling during tumorigenesis
Nature communications, 2018
YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
Cancers, 2018
Biochemical and Biophysical Research Communications, 2014
Hippo inactivation feeds tumor-initiating cells
Breast Cancer Research, 2012
Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine
Cells, 2021
YAP and TAZ: a signalling hub of the tumour microenvironment
Nature Reviews Cancer, 2019
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone
Scientific Reports, 2019
The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
Cell Discovery
YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma
Cellular Oncology
YAP oncogene overexpression supercharges colon cancer proliferation
Cell Cycle, 2012
The Hippo pathway in normal development and cancer
Pharmacology & therapeutics, 2018
A YAP/TAZ-Regulated Molecular Signature is Associated with Oral Squamous Cell Carcinoma
Molecular cancer research : MCR, 2015
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
Oncogene, 2011
YAP and the Hippo pathway in pediatric cancer
Molecular & cellular oncology, 2017
Reply to: “YAP in tumorigenesis: Friend or foe?”
Journal of Hepatology, 2015
TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis
Bioscience reports, 2016
Assays Used for Discovering Small Molecule Inhibitors of YAP Activity in Cancers
Cancers, 2022
Annals of Colorectal Research, 2019
The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors
Science signaling, 2018
Genes & Development, 2007
Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor
Clinical cancer research : an official journal of the American Association for Cancer Research, 2015
Molecular and Cellular Biology, 2008
Frontiers in Cell and Developmental Biology, 2019
Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
International journal of molecular sciences, 2017
YAP/TAZ Signalling in Colorectal Cancer: Lessons from Consensus Molecular Subtypes
Cancers
TAZ promotes cell proliferation and EMT and is inhibited by the Hippo pathway
Hippo in Gastric Cancer: From Signalling to Therapy
Cancers
Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
Cancer Research, 2010